These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17980149)

  • 21. Quantification of Cooperativity in Heterodimer-DNA Binding Improves the Accuracy of Binding Specificity Models.
    Isakova A; Berset Y; Hatzimanikatis V; Deplancke B
    J Biol Chem; 2016 May; 291(19):10293-306. PubMed ID: 26912662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The RXRalpha C-terminus T462 is a NMR sensor for coactivator peptide binding.
    Lu J; Chen M; Dekoster GT; Cistola DP; Li E
    Biochem Biophys Res Commun; 2008 Feb; 366(4):932-7. PubMed ID: 18088598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
    Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
    J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
    Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
    Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
    ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.
    Orlov I; Rochel N; Moras D; Klaholz BP
    EMBO J; 2012 Jan; 31(2):291-300. PubMed ID: 22179700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex.
    Almeida NMS; Bali SK; James D; Wang C; Wilson AK
    J Chem Inf Model; 2023 Dec; 63(23):7423-7443. PubMed ID: 37990410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA.
    de Vera IMS; Zheng J; Novick S; Shang J; Hughes TS; Brust R; Munoz-Tello P; Gardner WJ; Marciano DP; Kong X; Griffin PR; Kojetin DJ
    Structure; 2017 Oct; 25(10):1506-1518.e4. PubMed ID: 28890360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determinants of magnolol targeting both RXRα and PPARγ.
    Zhang H; Xu X; Chen L; Chen J; Hu L; Jiang H; Shen X
    PLoS One; 2011; 6(11):e28253. PubMed ID: 22140563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.
    Xu RX; Lambert MH; Wisely BB; Warren EN; Weinert EE; Waitt GM; Williams JD; Collins JL; Moore LB; Willson TM; Moore JT
    Mol Cell; 2004 Dec; 16(6):919-28. PubMed ID: 15610735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor.
    Fadel L; Rehó B; Volkó J; Bojcsuk D; Kolostyák Z; Nagy G; Müller G; Simandi Z; Hegedüs É; Szabó G; Tóth K; Nagy L; Vámosi G
    J Biol Chem; 2020 Jul; 295(29):10045-10061. PubMed ID: 32513869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural mechanism for signal transduction in RXR nuclear receptor heterodimers.
    Kojetin DJ; Matta-Camacho E; Hughes TS; Srinivasan S; Nwachukwu JC; Cavett V; Nowak J; Chalmers MJ; Marciano DP; Kamenecka TM; Shulman AI; Rance M; Griffin PR; Bruning JB; Nettles KW
    Nat Commun; 2015 Aug; 6():8013. PubMed ID: 26289479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.
    Wang N; Zou Q; Xu J; Zhang J; Liu J
    J Biol Chem; 2018 Nov; 293(47):18180-18191. PubMed ID: 30275017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNA.
    Azam F; Bello M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements.
    Temple KA; Cohen RN; Wondisford SR; Yu C; Deplewski D; Wondisford FE
    J Biol Chem; 2005 Feb; 280(5):3529-40. PubMed ID: 15572375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoid X receptor alpha (RXRalpha) helix 12 plays an inhibitory role in the recruitment of the p160 co-activators by unliganded RXRalpha/retinoic acid receptor alpha heterodimers.
    Liu H; Shaw CK; Reineke EL; Liu Y; Kao HY
    J Biol Chem; 2004 Oct; 279(43):45208-18. PubMed ID: 15310754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linked magnolol dimer as a selective PPARγ agonist - Structure-based rational design, synthesis, and bioactivity evaluation.
    Dreier D; Latkolik S; Rycek L; Schnürch M; Dymáková A; Atanasov AG; Ladurner A; Heiss EH; Stuppner H; Schuster D; Mihovilovic MD; Dirsch VM
    Sci Rep; 2017 Oct; 7(1):13002. PubMed ID: 29057944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization, transcriptional activity and nutritional regulation of peroxisome proliferator activated receptor gamma in Nile tilapia (Oreochromis niloticus).
    He AY; Liu CZ; Chen LQ; Ning LJ; Qin JG; Li JM; Zhang ML; Du ZY
    Gen Comp Endocrinol; 2015 Nov; 223():139-47. PubMed ID: 26002036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.